Who We Are

A New Family of intracellular peptides

Proteimax was founded in 2001 in Sao Paulo, Brazil by leading scientists, Prof. Emer S. Ferro and Andrea Sterman Heimann. Their initial goal was to develop a method of screening, identifying, and commercializing antibodies and naturally occurring peptides, which are small proteins, for the pharmaceutical industry and basic research.

The unique screening method that was developed by the Proteimax team allowed them to bring to market several antibodies with the ability to identify changes in receptors that are affected by specific stress conditions.

In 2006, the science team decided to point their screening method to the  mammalian endocannabinoid system in order to search for new peptides that can activate that system’s receptors. At the time, it was commonly thought that only cannabinoids can activate these receptors.

 

In 2007, after screening thousands of candidates, a new family of 54 peptides was discovered and registered. Some of these peptides modulate cannabinoid receptors. Based on current knowledge, they appear to show potential to solve some of the most pressing challenges of humanity, from obesity and type 2 diabetes to certain neurological disorders to the certain cancers.

 

team

 

Nimrod Elmish
Nimrod Elmish
Founder & CEO
Experienced executive in the Israeli start-up sector. During 2004-2012 established and managed one of the major angel clubs in  Israel, in 2012 establish Cardboard Technologies and lead it as its first CEO through all funding stages. Previously CEO of Cann10.
Andrea S Heimann
Andrea S Heimann, PhD
Founder & CTO
Holds several degrees in Molecular Sciences and Experimental Physiopathology. Years of unique and accumulated experience in the fields of Biochemistry, Biotechnology, Antibodies, GPCRs and screening for new drugs with emphasis in Molecular Biology.
Arnon Krongrad
Arnon Krongrad, MD
Founder & CSO

Surgeon, scientist, and entrepreneur. Cloned the rabbit androgen receptor. Co-authored first study showing cancer prevention w nutritional supplement. Introduced laparoscopic radical prostatectomy. Writes about food and fitness.

Prof. Emer S Ferro
Founder & Sc. Advisor

Currently holds full professor position at the University of São Paulo and is in charge on the Laboratory of Pharmacology of Intracellular Peptides that study the recycling of biological activity and the discovery of new peptide drugs.

Nir Manor
Nir Manor
Business Development Advisor
Over 25 years’ experience providing solutions to Direct-to-consumer players. Retail, Brands, Banks, Insurance, Healthcare across Europe and APAC, Serial entrepreneur, sold 3 companies to multinational strategic partners. Ex Global VP Commercial /BD at Nielsen MBA from INSEAD, BA from TAU.
Itamar Raz
Prof. Itamar Raz
Advisory Board Obesity & Diabetes

Itamar Raz, MD is board certified, full professor in
internal medicine, and was the Head of the Diabetes Unit at Hadassah Hebrew University Hospital between 2000-2015. He is currently Medical Director at the Diabetes Medical Center in Tel Aviv and the head of the Israeli council of diabetes, Prof. Raz has been involved in many various academic activities.

Frank Greenway
Prof. Frank Greenway
Advisory Board Obesity & Sleep

Frank Greenway, MD is Medical Director of the Pennington Biomedical Research Center at Louisiana State University. His interest includes supplements and medical foods for the metabolic and functional effects in the obese.

Gustavo H. Goldman
Prof. Gustavo H. Goldman
Scientific Advisor, Mycology & Fungal Diseases

Dr. Goldman is a Hans Fischer Senior Fellow and Professor at the University of São Paulo. He specializes in fungal genetics and antifungal resistance, with a focus on Aspergillus fumigatus. Dr. Goldman has authored 300+ publications, is a member of various societies, and received the 2021 ASM Moselio Schaechter Award. He received degrees from universities in Brazil, Belgium, and the USA.

Nimrod Elmish
Nimrod Elmish
Founder & CEO
Experienced executive in the Israeli start-up sector. During 2004-2012 established and managed one of the major angel clubs in  Israel, in 2012 establish Cardboard Technologies and lead it as its first CEO through all funding stages. Previously CEO of Cann10.
Andrea S Heimann
Andrea S Heimann, PhD
Founder & CTO
Holds several degrees in Molecular Sciences and Experimental Physiopathology. Years of unique and accumulated experience in the fields of Biochemistry, Biotechnology, Antibodies, GPCRs and screening for new drugs with emphasis in Molecular Biology.
Arnon Krongrad
Arnon Krongrad, MD
Founder & CSO

Surgeon, scientist, and entrepreneur. Cloned the rabbit androgen receptor. Co-authored first study showing cancer prevention w nutritional supplement. Introduced laparoscopic radical prostatectomy. Writes about food and fitness.

Prof. Emer S Ferro
Founder & Sc. Advisor

Currently holds full professor position at the University of São Paulo and is in charge on the Laboratory of Pharmacology of Intracellular Peptides that study the recycling of biological activity and the discovery of new peptide drugs.

Nir Manor
Nir Manor
Business Development Advisor
Over 25 years’ experience providing solutions to Direct-to-consumer players. Retail, Brands, Banks, Insurance, Healthcare across Europe and APAC, Serial entrepreneur, sold 3 companies to multinational strategic partners. Ex Global VP Commercial /BD at Nielsen MBA from INSEAD, BA from TAU.
Itamar Raz
Prof. Itamar Raz
Advisory Board Obesity & Diabetes

Itamar Raz, MD is board certified, full professor in
internal medicine, and was the Head of the Diabetes Unit at Hadassah Hebrew University Hospital between 2000-2015. He is currently Medical Director at the Diabetes Medical Center in Tel Aviv and the head of the Israeli council of diabetes, Prof. Raz has been involved in many various academic activities.

Frank Greenway
Prof. Frank Greenway
Advisory Board Obesity & Sleep

Frank Greenway, MD is Medical Director of the Pennington Biomedical Research Center at Louisiana State University. His interest includes supplements and medical foods for the metabolic and functional effects in the obese.

Gustavo H. Goldman
Prof. Gustavo H. Goldman
Scientific Advisor, Mycology & Fungal Diseases

Dr. Goldman is a Hans Fischer Senior Fellow and Professor at the University of São Paulo. He specializes in fungal genetics and antifungal resistance, with a focus on Aspergillus fumigatus. Dr. Goldman has authored 300+ publications, is a member of various societies, and received the 2021 ASM Moselio Schaechter Award. He received degrees from universities in Brazil, Belgium, and the USA.

Skip to content